MedTrace Logo

Effect of Preoperative Immunonutrition in Upper Digestive Tract

NCT04027088 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 178

Last updated 2019-08-20

No results posted yet for this study

Summary

Randomized, double-blind, multicenter clinical trial that will evaluate the effects of immuno-nutrition in the preoperative period in patients with cancer of the upper digestive tract (esophagus, stomach, and pancreas). The aim is to compare the specific effect of the immunonutrients respect to an equivalent formula in caloric-protein value but without immunonutrients, in the surgical evolution of the cancer patient.

Conditions

  • Immunonutrition
  • Gastric Cancer
  • Esophageal Cancer
  • Pancreas Cancer
  • Surgery--Complications

Interventions

DIETARY_SUPPLEMENT

Immunonutrition

It is a hypercaloric and hyperproteic dietary supplement formulated with immunonutrients: Arginin, nucleotides, omega-3, olive oil polyphenols, antioxidants and L-carnitine

DIETARY_SUPPLEMENT

Standard

It is a hypercaloric and hyperproteic dietary supplement formulated without immunonutrients

Sponsors & Collaborators

  • Complexo Hospitalario Universitario de A Coruña

    lead OTHER

Principal Investigators

  • Miguel Á Martínez-Olmos, PhD, MD · Complexo Hospitalario Universitario de Santiago

  • Alfonso Vidal-Casariego, PhD, MD · Complexo Hospitalario Universitario de A Coruña

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-10
Primary Completion
2021-08-10
Completion
2021-12-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04027088 on ClinicalTrials.gov